Baxter International Inc. (BAX) Shares Outstanding: 0.51
Is Baxter International Inc.’s shares outstanding high or low?
Baxter International Inc.'s shares outstanding of 0.51 is in line with its 5-year average of 0.51, near the high end of its 5-year range (0.50–0.51).
0.29% above its 12-month average of 0.51.
BAX Shares Outstanding Chart
BAX Average Shares Outstanding Chart
BAX Current vs Average Shares Outstanding Chart
BAX Shares Outstanding Metrics
SHARES OUTSTANDING
0.51
SHARES OUTSTANDING AVG TTM
0.51
SHARES OUTSTANDING AVG 3Y
0.51
SHARES OUTSTANDING AVG 5Y
0.51
SHARES OUTSTANDING AVG 10Y
0.52
SHARES OUTSTANDING AVG 15Y
0.53
SHARES OUTSTANDING AVG 20Y
0.56
CURRENT VS TTM AVG
+0.29%
CURRENT VS 3Y AVG
+0.93%
CURRENT VS 5Y AVG
+1.12%
CURRENT VS 10Y AVG
-1.36%
CURRENT VS 15Y AVG
-3.62%
CURRENT VS 20Y AVG
-7.65%
Share Structure
Shares Outstanding
513.00M
Float Shares
N/A
Stock Price
$20.49
Market Cap
$10.6B
Annual Shares Outstanding History
| Year | Weighted Average Shares | YoY Change |
|---|---|---|
| 2025 | 513.00M | +0.59% |
| 2024 | 510.00M | +0.79% |
| 2023 | 506.00M | +0.40% |
| 2022 | 504.00M | +0.40% |
| 2021 | 502.00M | -1.38% |
| 2020 | 509.00M | +0.00% |
| 2019 | 509.00M | -4.68% |
| 2018 | 534.00M | -1.66% |
| 2017 | 543.00M | -0.55% |
| 2016 | 546.00M | +0.18% |
| 2015 | 545.00M | +0.55% |
| 2014 | 542.00M | -0.18% |
| 2013 | 543.00M | -1.45% |
| 2012 | 551.00M | -3.16% |
| 2011 | 569.00M | -3.56% |
| 2010 | 590.00M | -2.80% |
| 2009 | 607.00M | -2.88% |
| 2008 | 625.00M | -2.95% |
| 2007 | 644.00M | -1.08% |
| 2006 | 651.00M | +4.66% |
| 2005 | 622.00M | +1.30% |
| 2004 | 614.00M | +7.06% |
| 2003 | 573.51M | +27.20% |
| 2002 | 450.88M | -16.75% |
| 2001 | 541.59M | -7.05% |
| 2000 | 582.68M | +0.46% |
| 1999 | 580.00M | +2.11% |
| 1998 | 568.00M | +2.16% |
| 1997 | 556.00M | +2.21% |
| 1996 | 544.00M | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
Baxter International Inc. Shares Outstanding Formula & Definition
Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Baxter International Inc. Shares Outstanding FAQ
- What is the shares outstanding for Baxter International Inc. (BAX)?
- The shares outstanding for BAX stock is 0.51.
- Is Baxter International Inc.'s shares outstanding high or low?
- Baxter International Inc.'s shares outstanding of 0.51 is in line with its 5-year average of 0.51, near the high end of its 5-year range (0.50–0.51).
- What is the TTM average shares outstanding for Baxter International Inc. (BAX)?
- The TTM average shares outstanding for BAX stock is 0.51.
- What is the 3Y average shares outstanding for Baxter International Inc. (BAX)?
- The 3Y average shares outstanding for BAX stock is 0.51.
- What is the 5Y average shares outstanding for Baxter International Inc. (BAX)?
- The 5Y average shares outstanding for BAX stock is 0.51.
- What is the 10Y average shares outstanding for Baxter International Inc. (BAX)?
- The 10Y average shares outstanding for BAX stock is 0.52.
- What is the 15Y average shares outstanding for Baxter International Inc. (BAX)?
- The 15Y average shares outstanding for BAX stock is 0.53.
- What is the 20Y average shares outstanding for Baxter International Inc. (BAX)?
- The 20Y average shares outstanding for BAX stock is 0.56.
Baxter International Inc. Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2025-12-31 | 0.51 |
| 2024-12-31 | 0.51 |
| 2023-12-31 | 0.51 |
| 2022-12-31 | 0.50 |
| 2021-12-31 | 0.50 |
| 2020-12-31 | 0.51 |
| 2019-12-31 | 0.51 |
| 2018-12-31 | 0.53 |
| 2017-12-31 | 0.54 |
| 2016-12-31 | 0.55 |
| 2015-12-31 | 0.55 |
| 2014-12-31 | 0.54 |
| 2013-12-31 | 0.54 |
| 2012-12-31 | 0.55 |
| 2011-12-31 | 0.57 |
| 2010-12-31 | 0.59 |
| 2009-12-31 | 0.61 |
| 2008-12-31 | 0.63 |
| 2007-12-31 | 0.64 |
| 2006-12-31 | 0.65 |
| 2005-12-31 | 0.62 |
| 2004-12-31 | 0.61 |
| 2003-12-31 | 0.57 |
| 2002-12-31 | 0.45 |
| 2001-12-31 | 0.54 |
| 2000-12-31 | 0.58 |
| 1999-12-31 | 0.58 |
| 1998-12-31 | 0.57 |
| 1997-12-31 | 0.56 |
| 1996-12-31 | 0.54 |
Related Metrics
About Baxter International Inc.
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Andrew Hider